Tago, Juanito, JR.. O.
HRN: 22-47-64 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/16/2023
CO-AMOXICLAV 625MG (TAB)
01/16/2023
01/23/2023
PO
625mg
Q8hrs
Appendicitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes